Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Karin Filipsson

Research project participant

Default user image.

Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).

Author

  • Marcus Lind
  • Irl B Hirsch
  • Jaakko Tuomilehto
  • Sofia Dahlqvist
  • Bo Ahrén
  • Ole Torffvit
  • Stig Attvall
  • Magnus Ekelund
  • Karin Filipsson
  • Bengt-Olov Tengmark
  • Stefan Sjöberg
  • Nils-Gunnar Pehrsson

Summary, in English

What are the effects of liraglutide, an incretin based treatment, on glycaemic control in people with type 2 diabetes treated with multiple daily insulin injections?

Department/s

  • Medicine, Lund
  • Nephrology
  • Clinical Sciences, Helsingborg
  • Diabetes - Molecular Metabolism
  • EXODIAB: Excellence in Diabetes Research in Sweden

Publishing year

2015

Language

English

Pages

5364-5364

Publication/Series

BMJ: British Medical Journal

Volume

351

Document type

Journal article

Publisher

BMJ Publishing Group

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Diabetes - Molecular Metabolism

ISBN/ISSN/Other

  • ISSN: 1756-1833